Tokyo Tape
Sign in
← GNI Group

Quarterly report · Q2

2160.TEDINET S100P1F0
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥4.2bn2022-04-01 → 2022-06-30dCons.Revenue IFRS
Revenue¥12.7bn2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥6.5bn2021-01-01 → 2021-06-30Cons.Revenue IFRS
Revenue¥2.6bn2021-04-01 → 2021-06-30dCons.Revenue IFRS
Operating income¥1.0bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥526m2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Operating income¥1.5bn2021-01-01 → 2021-06-30Cons.Operating profit loss IFRS
Operating income¥682m2021-04-01 → 2021-06-30dCons.Operating profit loss IFRS
Profit before tax¥790m2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥443m2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Profit before tax¥1.1bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.2bn2021-01-01 → 2021-06-30Cons.Profit loss before tax IFRS
Profit before tax¥522m2021-04-01 → 2021-06-30dCons.Profit loss before tax IFRS
Net income (owners)¥676m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥325m2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥1.1bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥941m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥509m2021-04-01 → 2021-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥198m2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥126m2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Net income¥55m2021-01-01 → 2021-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥745m2021-01-01 → 2021-06-30Cons.Profit loss IFRS
Net income¥309m2021-04-01 → 2021-06-30dCons.Profit loss IFRS
Total assets¥35.3bnat 2022-06-30Cons.Assets IFRS
Total assets¥30.3bnat 2021-12-31Cons.Assets IFRS
Total assets¥29.0bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥13.5bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥11.0bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥21.8bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥19.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥19.1bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥12.8bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥22.0bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥18.9bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥17.9bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥14.5bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.4bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.8bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.3bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥389m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥552m2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.1bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.5bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥261m2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.0bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥267m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥2.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥2.9bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥14.252022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥6.862022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥22.722021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥20.32021-01-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥10.782021-04-01 → 2021-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥14.182022-01-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥6.832022-04-01 → 2022-06-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.082021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥19.732021-01-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥10.592021-04-01 → 2021-06-30dCons.Diluted earnings loss per share IFRS
Equity ratio62.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio61.9%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue2022-01-01 → 2022-06-30¥1.2bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue external2022-01-01 → 2022-06-30¥1.2bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentsegment profit2022-01-01 → 2022-06-30¥526m
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue2022-01-01 → 2022-06-30¥7.0bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue external2022-01-01 → 2022-06-30¥7.0bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentsegment profit2022-01-01 → 2022-06-30¥479m
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.0bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue2021-01-01 → 2021-06-30¥1.0bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue external2021-01-01 → 2021-06-30¥1.0bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentsegment profit2021-01-01 → 2021-06-30¥390m
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue2021-01-01 → 2021-06-30¥5.5bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue external2021-01-01 → 2021-06-30¥5.5bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentsegment profit2021-01-01 → 2021-06-30¥1.1bn
—segment totalrevenue2021-01-01 → 2021-06-30¥6.5bn
—segment totalrevenue external2021-01-01 → 2021-06-30¥6.5bn
—segment totalsegment profit2021-01-01 → 2021-06-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 734
ItemContextValueUnit
Purchase of treasury shares ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember3085598000JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember57116000JPY
Put option for non controlling interest ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember57116000JPY
Other ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember207000JPY
Other ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember2615859000JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember2636889000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember-95000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-150631000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember124478000JPY
Total transactions with owners IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember124478000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember10884332000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember6227991000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-567000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember182675000JPY
Equity IFRSPrior1QuarterInstant_ShareAcquisitionRightsIFRSMember287832000JPY
Equity IFRSPrior1QuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember358004000JPY
Equity IFRSPrior1QuarterInstant_OtherComponentsOfEquityIFRSMember645837000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember11000032000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember1769072000JPY
Equity IFRSPrior2YearInstant12769104000JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember941326000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-196548000JPY
Profit loss IFRSPrior1YTDDuration744778000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember772409000JPY
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember130056000JPY
Other comprehensive income IFRSPrior1YTDDuration902465000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember1713735000JPY
Comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-66491000JPY
Comprehensive income IFRSPrior1YTDDuration1647243000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-3102911000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-794760000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration-3897672000JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-523254000JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration-523254000JPY
Dividends ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-150838000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass